LLOYD, Inc. products have been used by veterinarians and physicians around the world for over six decades to make the lives of animals and humans happier, healthier and more productive. From a modest beginning in 1958, Lloyd research and development has led to new pharmaceutical and nutritional products with the highest level of stability, safety and efficacy. From solid dosage pharmaceuticals and nutritional supplements to sterile injectables, Lloyd follows rigorous Good Manufacturing Practices (cGMPs) to ensure that all products marketed by Lloyd comply with current regulatory requirements. Over the years, as Lloyd expanded their market, they have maintained an aggressive pace in the expansion of our production, laboratory and distribution facilities to meet the customers’ demands.
Lloyd manufacturing plant provides full solid dosage tablet and powder manufacturing capabilities. From the moment raw materials are received to final shipment to customers, Lloyd monitor all phases of production to ensure their products meet the rigorous standards of the Food and Drug Administration (FDA) and other regulatory agencies, as well as the customers expectations.
Lloyd has collaborated with various regulatory organizations to support efforts to insure the best products are available for people and pets. Lloyd was responsible for developing the Levothyroxine Powder specification monograph for USP and is the only Levothyroxine Sodium Powder, USP available for horses worldwide. Lloyd markets over two hundred products/package sizes to more than forty thousand veterinarians and physicians in the U.S. and thousands more around the world. These products are used to aid in the treatment of diseases and nutritional deficiencies and to make surgery easier.